Results 301 to 310 of about 155,151 (336)

Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.

Molecular Pharmacology, 1993
K. Williams
semanticscholar   +1 more source

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

Nature, 1986
R. Morris, Elizabeth W. Anderson, G. Lynch, M. Baudry   +3 more
semanticscholar   +1 more source

Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.

Journal of Neurophysiology, 1998
S. Vicini, Jian Feng Wang, Jinhong Li, W. Zhu, Yue‐hua Wang, Jian‐hong Luo, B. Wolfe, D. Grayson   +7 more
semanticscholar   +1 more source

Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors

Brain Research, 1984
E. Harris, A. Ganong, C. Cotman
semanticscholar   +1 more source

Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

Pharmacological Reviews, 1998
W. Danysz, C. Parsons
semanticscholar   +1 more source

Principles of N-Methyl-d-aspartate Receptor Allosteric Modulation

Molecular Pharmacology, 2005
N-methyl-D-aspartate (NMDA) receptors are glutamate-gated ion channels with complex participation in synaptic transmission, integration, and plasticity. They are highly permeable to Ca(2+), activate with characteristic kinetics, and generate currents with distinct amplitudes according to stimulation frequency.
openaire   +2 more sources

Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons

Nature, 1990
S. Traynelis, S. Cull-Candy
semanticscholar   +1 more source

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

Molecular Pharmacology, 2004
A. Dunah, A. Sirianni, A. Fienberg, E. Bastia, M. Schwarzschild, D. Standaert   +5 more
semanticscholar   +1 more source

Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.

Journal of Pharmacology and Experimental Therapeutics, 1997
G. Fischer, V. Mutel, G. Trube, P. Malherbe, J. Kew, E. Mohacsi, M. Heitz, J. Kemp   +7 more
semanticscholar   +1 more source

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

International review of neurobiology, 2007
D. Javitt
semanticscholar   +1 more source